-
EP1399175
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1399175
| EP1399175 - THERAPEUTIC USE OF RANK ANTAGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.05.2006 Database last updated on 04.11.2024 | Most recent event Tooltip | 26.05.2006 | Application deemed to be withdrawn | published on 28.06.2006 [2006/26] | Applicant(s) | For all designated states Immunex Corporation Law Department, 51 University Street Seattle, WA 98101 / US | [N/P] |
| Former [2005/25] | For all designated states Immunex Corporation Law Department, 51 University Street Seattle, WA 98101 / US | ||
| Former [2004/13] | For all designated states Immunex CorporatioN Law Department, 51 University Street Seattle, WA 98101 / US | Inventor(s) | 01 /
DOUGALL, William, C. 7523 33rd Avenue NW Seattle, WA 98117 / US | 02 /
ANDERSON, Dirk, M. 3616 NW 64th Street Seattle, WA 98107 / US | [2004/13] | Representative(s) | Dörries, Hans Ulrich df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [N/P] |
| Former [2004/13] | Dörries, Hans Ulrich, Dr. Dörries, Frank-Molnia & Pohlman, Triftstrasse 13 80538 München / DE | Application number, filing date | 02726901.8 | 17.05.2002 | [2004/13] | WO2002US16002 | Priority number, date | US20010291919P | 17.05.2001 Original published format: US 291919 P | [2004/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO02092016 | Date: | 21.11.2002 | Language: | EN | [2002/47] | Type: | A2 Application without search report | No.: | EP1399175 | Date: | 24.03.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.11.2002 takes the place of the publication of the European patent application. | [2004/13] | Search report(s) | International search report - published on: | US | 03.04.2003 | (Supplementary) European search report - dispatched on: | EP | 13.10.2005 | Classification | IPC: | A61K38/00, A61K39/00, A61K48/00, C07H21/02, C07H21/04, C07K14/00, C07K14/47, G01N33/53 | [2004/13] | CPC: |
C07K16/2878 (EP,US);
A61P1/02 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P31/04 (EP);
A61P35/00 (EP);
A61P41/00 (EP);
A61P43/00 (EP);
A61P5/20 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
C07K14/70578 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/13] | Extension states | AL | 16.12.2003 | LT | 16.12.2003 | LV | 16.12.2003 | MK | 16.12.2003 | RO | 16.12.2003 | SI | 16.12.2003 | Title | German: | THERAPEUTISCHE VERWENDUNG VON RANG-ANTAGONISTEN | [2004/13] | English: | THERAPEUTIC USE OF RANK ANTAGONISTS | [2004/13] | French: | USAGES THERAPEUTIQUES D'ANTAGONISTES DE RANK | [2004/13] | Entry into regional phase | 16.12.2003 | National basic fee paid | 16.12.2003 | Search fee paid | 16.12.2003 | Designation fee(s) paid | 16.12.2003 | Examination fee paid | Examination procedure | 10.12.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 16.12.2003 | Examination requested [2004/13] | 13.02.2004 | Amendment by applicant (claims and/or description) | 01.12.2005 | Application deemed to be withdrawn, date of legal effect [2006/26] | 16.01.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2006/26] | Fees paid | Renewal fee | 13.05.2004 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.05.2005 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9958674 (IMMUNEX CORP [US], et al) [X] 1-3,7,8 * the whole document *; | [PX]WO0224896 (IMMUNEX CORP [US], et al) [PX] 1-3,7,8* the whole document *; | [A] - OYAJOBI B O ET AL, "Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.", CANCER RESEARCH. 15 MAR 2001, (20010315), vol. 61, no. 6, ISSN 0008-5472, pages 2572 - 2578, XP002301285 [A] 1-18 * the whole document * | [A] - WUYTS W ET AL, "Evaluation of the role of RANK and OPG genes in Paget's disease of bone.", BONE. JAN 2001, (200101), vol. 28, no. 1, ISSN 8756-3282, pages 104 - 107, XP002347622 [A] 1-18 * the whole document * DOI: http://dx.doi.org/10.1016/S8756-3282(00)00411-7 | International search | [A]US6271349 (DOUGALL WILLIAM C [US], et al); | [A]US6171860 (BAKER BRENDA F [US], et al); | [A]US6017729 (ANDERSON DIRK M [US]); | [A]US6433147 (NI JIAN [US], et al); | [A]US6482411 (AHUJA SEEMA S [US], et al); | [A]US2002086827 (ANDERSON DIRK M [US]); | [A]US6479635 (ANDERSON DIRK M [US], et al); | [A]US2002081720 (DOUGALL WILLIAM C [US], et al) |